---
figid: PMC8718269__BCJ-478-4071-g0004
figtitle: Functions of PARP5a/b, PARP7, and PARP9 in viral infection
organisms:
- NA
pmcid: PMC8718269
filename: BCJ-478-4071-g0004.jpg
figlink: /pmc/articles/PMC8718269/figure/BCJ-478-4071F4/
number: F4
caption: (A) HSV-1 infection induces PARP5a phosphorylation via ERK and promotes its
  expression and translocation to the nucleus by interacting with ICP0, which results
  in proteasome-dependent degradation of PARP5a, enhancing HSV replication. (B) PARP1
  or PARP5 binds and ADP-ribosylates EBNA1, which inhibits EBV replication. (C) PARP7
  mono-ADP-ribosylates TBK1 and down-regulates type I interferon response to viral
  infection; Upon SINV infection, PARP7 binds viral RNA and EXOSC5 (an exosome component)
  for RNA degradation. (D) IFN-induced overexpression of STAT1 up-regulates of PARP9
  and DTX3L. In turn, PARP9/DTX3L complex binds and promotes STAT1 phosphorylation,
  nuclear localization, and increases ISGs levels, and triggers degradation of EMCV
  3C proteases; (E) PARP9 recognizes viral dsRNA from RNA viruses and employs PI3K/AKT3
  pathway to phosphorylate IRF3 and IRF7 for inducing type I IFN, which inhibits the
  RNA virus infection. Created with BioRender.com.
papertitle: NAD+-consuming enzymes in immune defense against viral infection.
reftext: Jialin Shang, et al. Biochem J. 2021 Dec 10;478(23):4071-4092.
year: '2021'
doi: 10.1042/BCJ20210181
journal_title: Biochemical Journal
journal_nlm_ta: Biochem J
publisher_name: Portland Press Ltd.
keywords: immune response | macrodomain | NAD+-consuming enzymes | PARP | sirtuins
  | virus
automl_pathway: 0.941322
figid_alias: PMC8718269__F4
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC8718269__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8718269__BCJ-478-4071-g0004.html
  '@type': Dataset
  description: (A) HSV-1 infection induces PARP5a phosphorylation via ERK and promotes
    its expression and translocation to the nucleus by interacting with ICP0, which
    results in proteasome-dependent degradation of PARP5a, enhancing HSV replication.
    (B) PARP1 or PARP5 binds and ADP-ribosylates EBNA1, which inhibits EBV replication.
    (C) PARP7 mono-ADP-ribosylates TBK1 and down-regulates type I interferon response
    to viral infection; Upon SINV infection, PARP7 binds viral RNA and EXOSC5 (an
    exosome component) for RNA degradation. (D) IFN-induced overexpression of STAT1
    up-regulates of PARP9 and DTX3L. In turn, PARP9/DTX3L complex binds and promotes
    STAT1 phosphorylation, nuclear localization, and increases ISGs levels, and triggers
    degradation of EMCV 3C proteases; (E) PARP9 recognizes viral dsRNA from RNA viruses
    and employs PI3K/AKT3 pathway to phosphorylate IRF3 and IRF7 for inducing type
    I IFN, which inhibits the RNA virus infection. Created with BioRender.com.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EPHB2
  - MAPK1
  - MAPK3
  - TNKS
  - STAT1
  - IFNAR1
  - IFNAR2
  - DTX3L
  - PARP9
  - PARP1
  - ERVK-8
  - ERVK-10
  - ERVK-9
  - ERVK-21
  - ERVK-18
  - ERVK-25
  - ERVK-24
  - ERVK-19
  - TIPARP
  - IFNA1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - TBK1
  - IRF3
  - EXOSC5
  - AKT3
  - IRF7
  - IFNK
  - IFNW1
  - IFNA2
  - IFNA4
  - IFNA5
  - IFNA6
  - IFNA7
  - IFNA8
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA17
  - IFNA21
  - IFNB1
---
